Literature DB >> 28203400

Treatment of resectable stage IIIA non-small cell lung cancer.

Felipe Cardenal1, Ramón Palmero1.   

Abstract

Entities:  

Year:  2017        PMID： 28203400      PMCID： PMC5303075          DOI： 10.21037/jtd.2017.01.08

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  13 in total

1.  A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.

Authors:  Richard J Stephens; David J Girling; Penelope Hopwood; Nicholas Thatcher
Journal:  Lung Cancer       Date:  2005-09       Impact factor: 5.705

Review 2.  Outcome of surgery versus radiotherapy after induction treatment in patients with N2 disease: systematic review and meta-analysis of randomised trials.

Authors:  P J McElnay; A Choong; E Jordan; F Song; E Lim
Journal:  Thorax       Date:  2015-05-12       Impact factor: 9.139

3.  Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.

Authors:  Nirmal K Veeramachaneni; Richard H Feins; Briana J K Stephenson; Lloyd J Edwards; Felix G Fernandez
Journal:  Ann Thorac Surg       Date:  2012-06-27       Impact factor: 4.330

4.  Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.

Authors:  Sarah J Gao; Christopher D Corso; Elyn H Wang; Justin D Blasberg; Frank C Detterbeck; Daniel J Boffa; Roy H Decker; Anthony W Kim
Journal:  J Thorac Oncol       Date:  2016-10-05       Impact factor: 15.609

5.  A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903).

Authors:  Nobuyuki Katakami; Hirohito Tada; Tetsuya Mitsudomi; Shinzoh Kudoh; Hiroshi Senba; Kaoru Matsui; Hideo Saka; Takayasu Kurata; Yasumasa Nishimura; Masahiro Fukuoka
Journal:  Cancer       Date:  2012-06-06       Impact factor: 6.860

6.  Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group.

Authors:  David W Johnstone; Roger W Byhardt; David Ettinger; Charles B Scott
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

7.  Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial.

Authors:  Nicolas Girard; Françoise Mornex; Jean-Yves Douillard; Nadine Bossard; Elisabeth Quoix; Véronique Beckendorf; Dominique Grunenwald; Elodie Amour; Bernard Milleron
Journal:  Lung Cancer       Date:  2009-10-29       Impact factor: 5.705

8.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Authors:  Kathy S Albain; R Suzanne Swann; Valerie W Rusch; Andrew T Turrisi; Frances A Shepherd; Colum Smith; Yuhchyau Chen; Robert B Livingston; Richard H Feins; David R Gandara; Willard A Fry; Gail Darling; David H Johnson; Mark R Green; Robert C Miller; Joanne Ley; Willliam T Sause; James D Cox
Journal:  Lancet       Date:  2009-07-24       Impact factor: 79.321

9.  Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).

Authors:  Wilfried Ernst Erich Eberhardt; Christoph Pöttgen; Thomas Christoph Gauler; Godehard Friedel; Stefanie Veit; Vanessa Heinrich; Stefan Welter; Wilfried Budach; Werner Spengler; Martin Kimmich; Berthold Fischer; Heinz Schmidberger; Dirk De Ruysscher; Claus Belka; Sebastian Cordes; Rodrigo Hepp; Diana Lütke-Brintrup; Nils Lehmann; Martin Schuler; Karl-Heinz Jöckel; Georgios Stamatis; Martin Stuschke
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

10.  Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis.

Authors:  Shan Xian Guo; Yan Jian; Ying Lan Chen; Yun Cai; Qing Yuan Zhang; Fang Fang Tou
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.